603193.SS SHH
Runben Biotechnology
1W: -1.9%
1M: -2.1%
3M: +5.2%
YTD: -15.3%
1Y: -35.4%
¥20.25 ($3.02)
+0.25 (+1.25%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
📊 Key Metrics
TTM¥2B
Revenue
+15.9% YoY
¥352M
Net Income
+14.4% YoY
¥261M
Free Cash Flow
+114.4% YoY
60.7%
Gross Margin
24.8%
Op. Margin
21.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE15.6%
ROA14.4%
ROIC40.7%
Valuation
P/E23.0
P/B3.5
EV/EBITDA15.1
Leverage
Debt/Equity0.00
Current Ratio8.74
Interest Cov.6973.9x
Quality Scores
Piotroski F7/9
Altman Z23.90
Beneish M-2.31